Startups
Phi Pharma SA is a private Swiss-based biopharmaceutical company. It specializes in the discovery to early clinical development of drug conjugates for improving treatment of diseases with high-medical need. Phi Pharma technology allows development of a powerful new class of peptide drug conjugates through specific cellular targeting and efficient intra-cellular delivery. Company programs are in oncology and infectious diseases.
Overview
Location
Switzerland, Wallis, Sion
Employees
1-10
Total raised
$3.6M
Founded date
2012
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 20, 2016 | Phi Pharma SA announces closing of CHF 3.7 million series A financing |
Reviews 0
FAQ about Phi Pharma SA
When was Phi Pharma SA founded?
Phi Pharma SA was founded in 2012.
How much funding has Phi Pharma SA raised?
Phi Pharma SA has raised $3.6M in total across 1 funding round.
What has the press written about Phi Pharma SA?
Parsers VC has collected 2 articles mentioning Phi Pharma SA, among them “Phi Pharma SA announces closing of CHF 3.7 million series A financing” (Dec 20, 2016).
Is Phi Pharma SA still active?
Yes, Phi Pharma SA is active; its latest activity on Parsers VC dates from Apr 9, 2018.